Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast Cancer

Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Study ID
NCT00003730
Status
Completed

Conditions

Eligibility Criteria

Sex
FEMALE
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Randomized clinical trial to study the effectiveness of vinorelbine plus fluorouracil in treating women who have metastatic breast cancer that has been previously treated with at least one regimen of chemotherapy.

Key Dates

Start date
Dec 31, 1998
Status verified
Jun 2012
Primary completion
Nov 30, 2004

Study Design

Enrollment
80 participants (estimated)
Allocation
RANDOMIZED
Primary purpose
TREATMENT

Related Studies